Skip to content
Acting Auditions – Lifestyle
Author:
Biovica International
Biovica Expands Master Services Agreement with a Current Customer, a Leading Global Pharmaceutical Company, to Support Next-Generation Oncology Development
July 7, 2026
Biovica Granted Japanese Patent for Immuno-Oncology
July 1, 2026
Biovica Refocuses US Commercial Strategy and Terminates Agreement with Tempus AI
June 30, 2026
Correction: Biovica Refocuses US Commercial Strategy and Terminates Agreement with Tempus AI
June 30, 2026
Biovica International AB – Annual Report for The Financial Year 2025/2026 Published
June 30, 2026
Year-End Report 2025-2026
June 17, 2026
New phase III Translational Data Show DiviTum(R) TKa Captures Treatment-Specific Biological Response in Metastatic Breast Cancer
May 28, 2026
Biovica Receives Expanded Work Order from Clinical-Stage Oncology Company for Next-Generation CDK Inhibitor Program
May 26, 2026
Biovica International AB Announces Change in Executive Management
May 5, 2026
Waystar Reports First Quarter 2026 Results
April 30, 2026
1
2
Next Page
→